help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on December 15, 2005, doi:10.1165/rcmb.2005-0151OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0151OCv1
34/4/496    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janssen, R.
Right arrow Articles by van den Bosch, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janssen, R.
Right arrow Articles by van den Bosch, J. M.
American Journal of Respiratory Cell and Molecular Biology. Vol. 34, pp. 496-499, 2006
© 2006 American Thoracic Society
DOI: 10.1165/rcmb.2005-0151OC

The Mucin-1 568 Adenosine to Guanine Polymorphism Influences Serum Krebs von den Lungen-6 levels

Rob Janssen*, Adrian Kruit*, Jan C. Grutters, Henk J. Ruven, Wim B. Gerritsen and Jules M. van den Bosch

Heart Lung Center Utrecht, Department of Pulmonology, and Department of Clinical Chemistry, St. Antonius Hospital, Nieuwegein, The Netherlands

Correspondence and requests for reprints should be addressed to Dr. J. C. Grutters, Department of Pulmonology, St Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, the Netherlands. E-mail: j.grutters{at}antonius.net

Krebs von den Lungen (KL)-6 offers a new perspective as a disease marker in pulmonary diseases. The aim of this study was to analyze whether serum KL-6 levels are dependent on the functional adenosine to guanine mucin-1 (MUC1) gene polymorphism at nucleotide position 568 in a well-characterized white population. Polymorphisms were determined in 327 healthy, white individuals and 74 patients with sarcoidosis, using a PCR-sequence–specific primer assay. The serum KL-6 levels were measured by ELISA. Significant differences between serum KL-6 levels of healthy subjects who were grouped according to MUC1 568 genotype were observed (P < 0.0001) (mean ± SEM): AA (195.2 ± 9.9 U/ml; 95% confidence interval [CI], 175.7–214.8), AG (246.0 ± 8.6 U/ml; 95% CI, 229.0–263.1), and GG (302.6 ± 11.8 U/ml; 95%CI, 279.3–326.0). In the patients with sarcoidosis, the results were (mean ± SD): AA (550.1 ± 411.7; 95% CI, 380.2–720.1), AG (716.3 ± 452.4; 95% CI, 547.4–885.2), GG (1,151.0 ± 1122; 95% CI, 610.1–1692.0); P = 0.02. Comparison of the KL-6 levels in which the 568 genotype was ignored rendered 6 out of 74 (7.5%) misclassifications of "elevated" versus "normal" KL-6 levels or vice versa. In conclusion, the MUC1 568 A to G polymorphism may be of interest for diagnostic purposes because our study delivered in vivo evidence that it contributes to interindividual variations in KL-6 levels.

Key Words: KL-6 • Krebs von den Lungen-6 • mucin-1 • polymorphism







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.
  2009/2010 ATS Fellows Career Development Awards